Butterfly Needles Market Size, Share and Industry Report, 2028

Butterfly needles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Blood Collection, Blood Transfusion, Venipuncture, IV Rehydration, and Delivery of Medications) and End User (Hospitals, Clinics, Blood Banks, and Others)

Publication Month : Jan 2023

  • Report Code : TIPRE00023931
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 158
Inquire Before Buy

PRICING

$4550

$3640

The butterfly needles market is expected to grow from US$ 1,78,164 thousand in 2021 to US$ 3,09,647 thousand by 2028; it is estimated to grow at a CAGR of 8.3% from 2022 to 2028.

Butterfly needles are devices used for drawing blood or administering medications in veins. Patients who may be difficult to venipuncture, such as older adults, infants, and children, are often given butterfly needles. A butterfly needles is also known as a winged infusion set or a scalp vein set, as it has plastic wings on either side of the hollow needle. With their winged tubing structure, which allows greater flexibility, butterfly needles are much easier to use and less painful. Additionally, butterfly needles are commonly used to draw blood or administer medication for babies, young children, and the elderly.

Market Insights

Increasing Organic and Inorganic Strategies by Key Players

The key butterfly needles market players are taking up various organic and inorganic strategies, including mergers and acquisitions, expansions, and new product launches, to stay competitive.

  • In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringes, ambulatory infusion devices, and vascular access and vital care products. The company offers Saf-T Wing butterfly needles, a single-use needle for drawing blood from venous. ICU Medical has become a leading infusion therapy company with a larger global footprint after adding the Smiths product line to its portfolio.
  • In October 2020, Nipro Corporation announced that its consolidated subsidiary Nipro Medical Europe NV, established Nipro Medical Morocco in the Kingdom of Morocco, in Northern Africa, to sell Nipro medical devices. Nipro Corporation is a medical equipment manufacturing company that offers a wide range of butterfly needles. This expansion will help promote the butterfly needles market in North Africa.
  • In June 2020, Becton Dickinson Benelux NV launched BD Vacutainer UltraTouch Push Button Blood Collection Set with Pre-Attached Holder. A pre-attached holder prevents accidental needlestick injury due to the nonpatient (tube-side) needle and helps ensure compliance with OSHA's single-use holder requirements.

Thus, many organic and inorganic strategies in the butterfly needles market enable healthcare professionals to provide improved services. These strategies help key players meet the rising demand for butterfly needles that can efficiently manage patients suffering from chronic disease conditions.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Butterfly needles Market: Strategic Insights

butterfly-needles-market
Market Size Value inUS$ 1,78,164 Thousand in 2021
Market Size Value byUS$ 3,09,647 thousand by 2028
Growth rateCAGR of 8.3% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

In the past several decades, countries in the Middle East & Africa have strengthened their health systems and upgraded public and commercial healthcare. However, the limited availability of resources—including trained staff and medical equipment—and the burden of noncommunicable diseases harm the overall healthcare system in the region. In 2020, the COVID-19 pandemic significantly impacted the delivery and accessibility of social services, education, health and nutrition, healthcare spending, and well-being and development-related businesses in the Middle East & Africa. Due to the region's dependence on trade and tourism and struggles with substantial youth unemployment, the global crisis led to serious long-term effects on the region. Governments in the Middle East & Africa allocated funds to prevent the overburdening of their health systems and decelerate the spread of COVID-19; a few countries also emphasized on increasing the number of intensive care units and hospital beds

Further, according to a report in November 2020 by Organization for Economic Co-operation and Development (OECD), the report says that prevention and treatment services for cardiovascular disease, cancer, and diabetes have been severely disrupted since the pandemic began. Additionally, in September 2021, the American College of Cardiology reported that diagnostic cardiovascular procedures declined an average of 47% in Asia in March 2020 compared to March 2019. The decline in the region was severe among all low-income countries, and some Asian countries even saw an 80% decline. According to a report, “COVID-19 and older people in Asia Pacific: 2020 in review”, Asia Pacific accounted for the highest number of older people's death during COVID-19 in all countries. Thus, there has been a negative impact on the butterfly needles market during the first quarter of the COVID-19 period due to the lockdown and limited access to healthcare-related settings. However, post-COVID, there has been a high demand for butterfly needles owing to the rising demand for cardiovascular disease, cancer, and diabetes treatment that contributes to the butterfly needles market’s future growth.

Application Insights

Based on application, the global butterfly needles market is divided into blood collection, blood transfusion, venipuncture, IV rehydration, and delivery of medications. The blood collection segment held the largest share of the butterfly needles market in 2021 and is expected to grow at the highest CAGR during the forecast period. The major driving factors for the segment's growth are the blood donation camps and key players' contributions to promote the butterfly needles market growth for the segment.

Butterfly needles Market, by Product – 2021 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
End User Insights

Based on end user, the butterfly needles market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospitals segment held the largest share of the market in 2021. The rise in chemotherapy, the increase in the number of hospitals, and the rise in surgical procedures for various CVDs across the globe are driving the hospitals segment of the global butterfly needles market.

Inorganic developments such as mergers and acquisitions are highly adopted strategies by companies in the Butterfly needles Market. A few of the recent key market developments are listed below:

  • In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringes, ambulatory infusion devices, vascular access, and vital care products.
  • In October 2020, Nipro’s consolidated subsidiary Nipro Medical Europe N.V. established the local subsidiary Nipro Medical Morocco in the Kingdom of Morocco, located in the northwestern part of North Africa, to engage in sales of Nipro medical devices. The new sales subsidiary started operations on October 1, 2020.
  • In June 2020, Becton Dickinson Benelux N.V. launched BD Vacutainer UltraTouch Push Button Blood Collection Set with Pre-Attached Holder. A pre-attached holder prevents accidental needlestick injury due to the nonpatient (tube-side) needle and helps ensure compliance with OSHA's single-use holder requirement.

Company Profiles

  • Braun Melsungen AG
  • Becton, Dickinson And Company
  • Nipro Corporation
  • Cardinal Health, Inc
  • Medline Industries, Inc.
  • Terumo Corporation
  • Kawasumi Laboratories, Inc
  • IUC Medical
  • ISO-MED Inc
  • Vogt Medical Vertrieb Gmbh
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are butterfly needles?

Butterfly needle also called as winged infusion set or a scalp vein set is used to access a vein to draw blood or give medications. The advantages of butterfly needless over straight needle are that it allows for more precise placement, particularly in hard-to-access veins. Growth of the global butterfly needless market is majorly driven by rise in prevalence of chronic diseases and advantages of butterfly needless over straight needles. However, risk associated with butterfly needlestick injuries is hampering market growth.

What are the driving factors for the global butterfly needles worldwide?

The factors driving the growth of butterfly needles are increasing prevalence of chronic diseases and advantages of butterfly needles over straight needles.

What are the restraining factors for the global butterfly needles worldwide?

Risks associated with butterfly needlestick injuries are expected to restrict the butterfly needles market growth during the forecast period.

Who are the major players in butterfly needles across the globe?

The butterfly needles majorly consist of the players, such as B. Braun SE, Becton Dickinson and Co, Nipro Corp, Cardinal Health Inc, Medline Industries Inc, Terumo Corp, SB-Kawasumi Laboratories Inc, ICU Medical Inc, ISO-MED Inc, and Vogt Medical Vertrieb GmbH among others.

Which segment is dominating the butterfly needles market?

The global butterfly needles based on the application are segmented into blood collection, blood transfusion, venipuncture, IV rehydration, and delivery of medications. The blood collection segment held the largest share of the market in 2021 and is expected to grow at the highest CAGR during the forecast period.

Which region is dominating the butterfly needles market?

The global butterfly needles based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 9.1% during the forecast period

The List of Companies - Butterfly Needles Market

  1. B. Braun SE
  2. Becton Dickinson and Co
  3. Nipro Corp
  4. Cardinal Health Inc
  5. Medline Industries Inc
  6. Terumo Corp
  7. SB-Kawasumi Laboratories Inc
  8. ICU Medical Inc
  9. ISO-MED Inc
  10. Vogt Medical Vertrieb GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Butterfly needles Market